United States· US:82667-300_4dc9b9f7-e722-51ce-e063-6394a90a5219
IHEEZO
A chloroprocaine product containing chloroprocaine hydrochloride, registered in United States by Harrow Eye, LLC. The same ATC class is registered in 2 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Chloroprocaine is registered in 2 of 19 countries.
Countries holding a registration under ATC S01HA08 (chloroprocaine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 2 of them publish a price we can compare per daily dose
Chloroprocaine · ATC S01HA08
2 / 19 countries
- Switzerlandprice
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CHLOROPROCAINE HYDROCHLORIDE
- Manufacturer
- Harrow Eye, LLC
- Country
- United States (US)
- ATC code
- S01HA08
- ATC class
- Chloroprocaine
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc1182667-300-00
- ndc1182667-300-01
- ndc1182667-300-05
- ndc1182667300001 POUCH in 1 CARTON (82667-300-00) / 1 VIAL in 1 POUCH / 800 mg in 1 VIAL
- ndc1182667300011 POUCH in 1 CARTON (82667-300-01) / 1 VIAL in 1 POUCH / 800 mg in 1 VIAL
- ndc1182667300055 POUCH in 1 CARTON (82667-300-05) / 1 VIAL in 1 POUCH / 800 mg in 1 VIAL
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chloroprocaine in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandAmpres 10 mg/ml, soluzione iniettabileSintetica SA
- GermanyAmpresSintetica Gmbh
- BelgiumAmpres 10 mg/mlNordic Group
- SpainAMPRES 10 MG/ML SOLUCION INYECTABLEB Braun Medical S.A.
- FinlandAmpresB. Braun Melsungen AG
- United KingdomAmpres 400mg/20ml solution for injection vialsB.Braun Medical Ltd
- IrelandAmpres 10mg/ml solution for injectionB. Braun Melsungen AG
- SwedenAmpres 10 mg/ml Injektionsvätska, lösningB. Braun Melsungen AG
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Ampres, Visiclor
- Belgium · Ampres
- Bulgaria · Ампрес
- Germany · Ampres, Decelex
- Denmark · Ampres
- Estonia · Clorotekal
- Spain · Ampres
- Finland · Ampres
- France · Clorotekal
- United Kingdom (Northern Ireland) · Ampres
- Greece · Ampres
- Croatia · Clorotekal
- Hungary · Clorotekal
- Italy · Decelex
- Luxembourg · Ampres
- Latvia · Clorotekal
- Netherlands · Ampres
- Norway · Ampres
- Poland · Ampres
- Portugal · Ampres
- Sweden · Ampres
- Slovenia · Decelex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f85adb37-c93c-430c-a8dc-fb7b397e325b GET /v1/drugs/f85adb37-c93c-430c-a8dc-fb7b397e325b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "OPHTHALMIC",
"source": "ndc",
"strength": "24",
"substance": "CHLOROPROCAINE HYDROCHLORIDE",
"productndc": "82667-300",
"dosage_form": "GEL",
"dea_schedule": null,
"strength_unit": "mg/800mg",
"application_number": "NDA216227",
"marketing_category": "NDA"
}See everything about chloroprocaine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.